Outcome Measurement Instruments Used to Evaluate Dermatologic Adverse Events in Cancer Trials: A Systematic Review.

Saved in:
Bibliographic Details
Title: Outcome Measurement Instruments Used to Evaluate Dermatologic Adverse Events in Cancer Trials: A Systematic Review.
Authors: Shaigany S; Northwell Health, New Hyde Park, New York.; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York.; Northwell Health Cancer Institute, New Hyde Park, New York., Mastacouris N; Northwell Health, New Hyde Park, New York., Tannenbaum R; Northwell Health, New Hyde Park, New York., Strunk A; Northwell Health, New Hyde Park, New York., Luan C; Northwell Health, New Hyde Park, New York., Burshtein J; Northwell Health, New Hyde Park, New York., Burshtein A; Northwell Health, New Hyde Park, New York., Carvajal R; Northwell Health, New Hyde Park, New York.; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York.; Northwell Health Cancer Institute, New Hyde Park, New York., Garg A; Northwell Health, New Hyde Park, New York.; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York.; Northwell Health Cancer Institute, New Hyde Park, New York., Alloo A; Northwell Health, New Hyde Park, New York.; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York.; Northwell Health Cancer Institute, New Hyde Park, New York.
Source: JAMA dermatology [JAMA Dermatol] 2024 Jun 01; Vol. 160 (6), pp. 651-657.
Publication Type: Systematic Review; Journal Article
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2168-6084
DOI:10.1001/jamadermatol.2024.0053